Current Nutrition Reports

, Volume 2, Issue 4, pp 174–180

Role of Diet and Diet Interventions in Diabetic Patients: Physiological and Metabolic Changes and Reduction in Morbidity and Mortality

  • Rosalba Giacco
  • Claudia Vetrani
  • Ettore Griffo
  • Angela A. Rivellese
Diabetes and Obesity (A Sánchez-Villegas, Section Editor)

DOI: 10.1007/s13668-013-0063-1

Cite this article as:
Giacco, R., Vetrani, C., Griffo, E. et al. Curr Nutr Rep (2013) 2: 174. doi:10.1007/s13668-013-0063-1

Abstract

Evidence of the impact of diet and dietary components on cardiovascular risk factors and morbidity/mortality in diabetic patients over the last 3 years is reviewed. The review comprises a section focusing on the effects of diet on body weight reduction and other cardiovascular risk factors, and a section in which recent evidence on hard endpoints are discussed. Overall, the data accumulated in the period considered seem to confirm the recommendations for diabetes management. More intervention studies focusing on hard endpoints in dia-betic subjects are needed to prove in a definitive way the role of diet on the reduction of cardiovascular morbidity and mortality, especially that concerning weight reduction.

Keywords

Diabetes Dietary pattern Risk factors Cardiovascular events Cardiovascular mortality 

Introduction

Diet is recognized as one of the cornerstones in the treatment of diabetes, having as primary goals not only the improvement in blood glucose control and other metabolic cardiovascular (CV) risk factors [1, 2], but also the reduction of cardiovascular disease (CVD), which accounts for about 70 % of total mortality in these patients [3].

Moreover, since diet and its components may act on the reduction of CV risk through different mechanisms, having pleiotropic effects, a healthy diet may be particularly important in patients characterized by the aggregation of multiple risk factors (overweight/obesity, poor glycemic control, dyslipidemia and high blood pressure). Nevertheless, little is known about this task in diabetic patients, at least for what concerns intervention studies with hard endpoints, such as incidence of CV morbidity and mortality.

Hence, this review will mainly take into account the papers published in the last 3 years that have evaluated the effects and possible mechanisms of action of the diet on metabolic parameters, CVD risk factors, and CV morbidity and mortality in diabetic patients.

Since some studies have investigated the role of diet in primary prevention of diabetes, a brief summary of the evidence on this aspect is included.

Diet and Type 2 Diabetes Prevention

As reported above, almost 70 % of total mortality in patients with type 2 diabetes (T2D) is due to CVD. Since T2D is increasing throughout the world, a reduction in CVD could be achieved by preventing the development of this disease, which is strongly linked to westernized dietary patterns, physical inactivity and rising rates of obesity.

In the last three decades, several studies have tried to clarify the relation existing between food groups or dietary patterns and the risk of T2D, as well the effects of lifestyle modification and dietary changes on the risk to develop T2D.

More recently, two observational studies have provided further information on the role of food consumption or Mediterranean diet on T2D risk. The first, the EPIC-Potsdam study, has confirmed in line with previous studies that higher intake of whole-grain bread, fruits, raw vegetables and coffee is inversely associated with T2D risk in a large cohort of healthy subjects, during an average follow-up of 8 years [4]. Conversely, high intake of red meat, butter, sauces and low-fat dairy is associated with an increase of T2D risk.

The InterAct study has confirmed that an higher adherence to a Mediterranean dietary pattern is associated with a significant reduction (-12 %) in the risk of developing T2D compared with individuals with lower adherence to Mediterranean diet in a large cohort of healthy subjects from Mediterranean and non-Mediterranean countries [5].

The role of dietary patterns, in particular of the Mediterranean diet, in the reduction of T2D risk has been clearly reinforced by results of the PREDIMED study, investigating the effects of two Mediterranean diets (MedD) supplemented with extra-virgin olive oil or mixed nuts versus a low-fat diet on incidence of diabetes in individuals of middle age having at least three CV risk factors [6]. After a median follow-up of 4 years, a multivariable adjusted hazard ratio has been almost 50 % lower in the participants assigned to the two MedD compared to the control diet. In addition, in all arms of the study, increased adherence to MedD has been inversely associated with diabetes. We underline that in this study, the reduction of T2D risk has been observed in the absence of significant changes in body weight or physical activity, suggesting that the mechanisms involved in diabetes risk reduction are independent of body weight loss and could be linked to other mechanisms, such as improvement in β-cell function, reduction of oxidative stress and inflammation.

In addition to the effect of diet composition, new data from the Diabetes Prevention Study (DPS) have further outlined the importance of overall lifestyle modifications on the reduction of T2D; in fact, the benefits of moderate weight reduction, together with an increase of physical activity, are preserved in the long-term, even many years after the conclusion of the intervention [7].

Although lifestyle interventions are not easily applicable in real-life settings, the European Diabetes Prevention Study (EDIPS) has recently shown that the DPS protocol can be applied in other European countries with success, reducing by 57 % the cumulative T2D incidence during a mean follow-up of 3.1 years [8].

Diet in Diabetic Patients

This section will address evaluating the effects of different diets on body weight and other CV risk factors.

Body Weight

Overweight and obesity are the most important modifiable risk factors for T2D and CVD. As a matter of fact, it is well known that abdominal adiposity induces insulin resistance and, consequently, an increased steady requirement for insulin secretion. This condition represents a stressful state that can lead, over the time, to β-cell function decline with deterioration of blood glucose control. Moreover, excessive body weight is associated with an increase in many of the most important CV risk factors.

Therefore, in overweight or obese individuals with T2D, evidence-based recommendations suggest that weight loss is the first step of T2D management, because the improvement of insulin resistance and of β-cell function may be able to improve glucose metabolism, induce partial or total remission of diabetes and reduce the other CV risk factors linked to overweight/obesity.

In the last 3 years, some studies have clearly shown the benefits of intensive dietary interventions and lifestyle changes on body weight and metabolic parameters.

Intensive individualized dietary intervention, based on the nutritional recommendations of the European Association for the Study of Diabetes, is able to improve blood glucose control, and reduce body weight and waist circumference compared to usual care in diabetic patients not adequately controlled despite optimized hypoglycemic treatment [9].

Regarding lifestyle changes, the long-term results of the Action for Health in Diabetes trial (Look AHEAD) have been published. The Look AHEAD trial is the first study that has investigated the effects of a moderate body weight reduction, obtained by an intensive lifestyle intervention that combined a moderate energy restriction of diet with a daily increase of physical activity, on several CV risk factors and the incidence of CV events and mortality in a large cohort of overweight and obese individuals with T2D. In relation to CV risk factors, results of the study have shown that the intensive lifestyle intervention, compared with an usual education program, represents a good strategy to reduce body weight, and significantly improve blood pressure and metabolic profile in the long-term (4 years of follow-up) [10••]. In addition, in a small number of patients, the intervention is even able to induce a partial or total remission of type 2 diabetes [11]. Noteworthy is the sustained effect of lifestyle intervention on HDL-cholesterol (HDL-col). In contrast to several other risk factors, the effect for HDL-col is greater at 4 years than at 1 year; at each year, HDL-col in the lifestyle group is approximately 8-9 % higher than baseline levels, whereas in the control group, it is 3-6 % above baseline. Interestingly, although severely obese participants have not reached their ideal body weight, a significant reduction of blood pressure, glucose, HbA1c and triglycerides has been achieved, confirming the benefits of moderate weight loss (7–10 % of initial body weight) in the management of T2D metabolic abnormalities. However, the improvement in CV risk factors reported in this study has been achieved with great investment in terms of economic and professional resources; hence, this approach is not easily applicable in clinical practice, and more feasible strategies should be identified.

An easier approach based on additional time for dietary support (6.5 hours/years more than usual clinical practice) has been applied in the Early ACTID trial [12••] within the context of UK National Health Service. The results have confirmed the effectiveness of dietary intervention to reduce body weight and medication need, and to improve glucose homeostasis in 1 year’s time. With respect to the increase of physical activity, no additional benefits have been observed for risk factor improvement or on the magnitude of body weight reduction. It can be hypothesized that this result is due to the lack of real increase in physical activity, since only general advice was given to participants, rather than a controlled physical exercise program.

Considering the importance of weight reduction and the challenge in achieving and maintaining stable weight loss, much attention has been always placed on the most effective dietary composition to decrease body weight and improve other CV risk factors in people with T2D. In this respect, a recent meta-analysis [13•] has tried to give answers to this question. On the basis of 20 clinical trials, the results of this meta-analyses seem to suggest that: a) different types of diet (low-carbohydrate, low-glycemic index, Mediterranean and high-protein diets) are all effective in blood glucose control; b) low-carbohydrate and Mediterranean diets are more effective in reducing body weight. However, as pointed out in the editorial done on this meta-analyses [14], the results should be considered with caution because the studies analyzed are few—especially for some outcomes (i.e. body weight)—quite heterogeneous, and the control diet is often not very well characterized.

Hence, this new evidence reinforces the concept that energy intake reduction seems to be more important than the qualitative composition of the diet, at least for weight loss, as we have recently reviewed [15].

In relation to energy restriction, the potential mechanisms triggered by it, independent from body weight loss, have been investigated by two recent trials, focusing on the effects of a very-low calorie diet (VLCD) in patients with T2D [16, 17]. Findings of these two studies demonstrate that short-term (1 week) caloric restriction per se can improve glucose control, β-cell function and insulin sensitivity, independently from weight-loss.

In particular, Lim and colleagues [16] have demonstrated a clear “multi-step” mechanism behind the observed effects, primarily involving changes in hepatic insulin sensitivity, followed by a slower change in the β-cell function. Moreover, the normalization of both β-cell function and hepatic insulin sensitivity in T2D is associated with decreased pancreatic and liver triglycerides content, which has been linked to T2D etiology.

Other Cardiovascular Risk Factors

Several trials have been carried out to assess potential benefits of diet quality on CV risk factors in diabetic subjects, independent from body weight changes.

Carbohydrates represent the first target of dietary treatment of diabetes. A recent meta-analysis on randomized controlled trials has shown the importance of the amount and types of carbohydrates in the regulation of glucose levels. The results suggest that increasing dietary fiber intake with high-fiber diets or soluble and insoluble fiber supplements may positively influence glucose homeostasis (decreasing fasting blood glucose by 15.32 mg/dl and HbA1c by 0.26 %) in patients with T2D [18•].

Conversely, in a previous meta-analysis [19•] considering the effect of high carbohydrate/low fat diet compared with low carbohydrate/high fat diet, no diet-related effects on Hb1Ac and blood glucose have been observed. Moreover, the high-carbohydrate diet increases fasting plasma insulin and triglyceride levels by 8 and 13 %, respectively, and lowers the HDL cholesterol level by 6 %. This meta-analysis excluded all studies in which the high-carbohydrate diet was also high in fiber and, thus, clearly demonstrates that replacement of fat by carbohydrate foods low in fiber may adversely affect insulin resistance and the metabolic profile in patients with T2D. This is at odds with what happens when fat is substituted with carbohydrate foods that are also rich in fiber and/or with low glycemic index, reinforcing the concept that the quality of carbohydrates is more important than the amount from a metabolic point of view.

Among fibers, their different properties seem to be important in relation to glucose and lipid control. Soluble fibers are more effective than insoluble ones in reducing fasting glucose, HbA1c, urinary glucose excretion and serum cholesterol, as recently reviewed by Wolever [20].

Oxidative Stress and Inflammation

Oxidative stress and inflammation are considered additional pathophysiologycal conditions linked to the development of CVD and T2D.

Epidemiological and clinical evidence shows that diet composition can influence oxidative stress in T2D or high CV-risk subjects, as recently reviewed [21]. In particular, fruit and vegetables reduce oxidative damage and this effect could be triggered by several mechanisms, inducing an improvement of antioxidant defenses and DNA repair enzymes. In addition to this, the type of dietary fat influences oxidative balance: monounsaturated fatty acids (MUFA) and saturated fatty acids (SFA) have opposite actions on oxidative stress (beneficial and detrimental, respectively), possibly because of their different chemical properties. Higher amounts of lipoprotein richer in SFA than in unsaturated fatty acids could affect receptor responsiveness in the liver, inducing an increase in low-density lipoprotein levels and making them more prone to oxidation, a condition linked to an increased atherosclerotic plaques formation.

Moving to inflammation, weight-loss-mediated improvement of C-reactive protein (CRP) has been observed [22], whereas trials focusing on quality of diet have provided inconsistent results. A high carbohydrate/high-fiber/low-glycemic index or a high-MUFA diet have shown similar effects on fasting CRP concentrations, whereas a small but significant decrease in postprandial CRP levels has been observed with the high-MUFA diet [23].

The source of fiber could have a critical role in the influence on inflammatory status. In fact, in our experience, a diet rich in whole wheat-fiber products has no effect on inflammation markers [24], whereas de Mello and colleagues [25] have shown that whole rye bread induces a significant reduction in CRP levels. This difference could be also due to other compounds contained in rye products besides fiber.

Liver Fat

It is well known that T2D is independently associated with nonalcoholic fatty liver disease (NAFLD) [26], a condition that has been recognized as a possible emerging CV risk factor. Moreover, excessive liver fat content is associated with a reduction of peripheral and hepatic insulin sensitivity that can aggravate metabolic abnormalities in diabetic subjects.

As demonstrated by the Look AHEAD trial, weight loss (8 % of body weight) can significantly reduce liver fat in type 2 diabetic subjects after 12 months [27].

However, the quality of the diet can also significantly affect liver fat independent of weight loss; in fact, it has been shown that a MUFA-rich diet is able to reduce liver fat by almost 30 % in type 2 diabetic subjects, without any change in body weight [28••].

Diet and Cardiovascular Morbidity/Mortality

The inverse relationship between consumption of a healthy diet (Mediterranean diet, Dietary Approach to Stop Hypertension [DASH] diet, Prudent diet, whose quite similar characteristics are shown in Table 1) and CVD has been found in many large prospective studies in non-diabetic populations [29, 30, 31].
Table 1

Main characteristics of dietary patterns linked to reduction of cardiovascular disease

Dietary pattern

Main characteristics

Mediterranean diet

↑ vegetables, legumes, fruit, nuts, whole grains, low-glycemic index foods, low-fat cheese or yogurt, fish, poultry, MUFA (from extra-virgin olive oil)

↓ red meats, refined cereals

DASH diet

↑ vegetables, legumes, nuts, fruit, whole grains, low-fat dairy products

↓ sodium, red and processed meat, high fat dairy products, refined cereals, sweetened beverages

Prudent diet

↑ vegetables, fruit, legumes, whole grains, fish

↓ red and processed meat, butter, high fat dairy products, eggs, refined cereals

DASH: Dietary Approach to Stop Hypertension; MUFA: monounsaturated fatty acids

Now, some data are available also for diabetic patients (Table 2).
Table 2

Diet and cardiovascular outcomes in diabetic patients

Observational studies

Reference

Participants

Study design

Follow-up

Outcome

[32••]

n = 31,546

Diabetics/ CVD

Prospective

4.8 years

↓ CV events

[33]

n = 912

Type 2 diabetics

Cross-sectional

-

↓ mortality rate with ↑ vegetables and fish

Tendency for worse prognosis with ↑ sugars and fats

[34••]

n = 2,108

Type 1 diabetics

Prospective

7.3 years

↓ CV mortality with ↑ dietary fiber

Intervention studies

Reference

Participants

Study design

Duration

Outcome

[35••]

n = 5,145

Diabetics

Parallel groups

a) Intensive lifestyle intervention

b) Support and education program

4 years

No difference in CV events

[38••]

n = 7,447

Diabetics or at least one criteria for MS

Parallel groups

a) MedD + EVO

b) MedD + nuts

c) Control

5 years

↓ CV events for both MedD

CV: cardiovascular; CVD: cardiovascular disease; EVO: extra-virgin olive oil; MedD: Mediterranean diet; MS: metabolic syndrome

↓: reduction; ↑: increase

First of all, a greater adherence to a healthy diet, characterized by high consumption of vegetables, fruit, whole grains, nuts and a higher intake of fish relative to meat, poultry and eggs, is associated with a significant reduction of recurrent CV events (- 20 %) in a large cohort of patients with previous CVD and/or diabetes. These data show that a healthy diet may be important not only in primary prevention, but also in secondary prevention or in high CV-risk individuals, such as diabetic patients. Moreover, the beneficial effects are in addition to those of pharmacological therapy generally used in secondary prevention [32••].

In a cross-sectional study in a cohort of elderly Japanese diabetics, no significant reduction of diet-related fatal events was observed, even if lower mortality rate was detected in those following a vegetables and fish-rich diet. Furthermore, the survival analyses showed a tendency for worse prognosis in high sugar and fat consumers [33].

The association between diet and mortality in type 1 diabetic subjects has been poorly investigated.

EURODIAB is the first European prospective study considering this task; the results have shown that, in a cohort of almost 2,000 subjects, a 5 g-increase of fiber intake, especially soluble fiber, within the range commonly consumed in patients with type 1 diabetes (11.3–28.3 g/day) is associated with lower CVD mortality (-16 %) and all-cause mortality (-28 %) [34••], confirming the importance of dietary fibers in diabetes management, also concerning type 1 diabetes.

Of course, the association between diet and CV risk in epidemiological studies generates hypotheses, but does not provide a casual relationship.

To answer this question, intervention studies are needed. Very recent evidence from two trials is available on this topic.

First of all, the Look AHEAD [10••] trial has shown that an intensive lifestyle modification program focused on weight reduction is able to improve all CV risk factors, as reported above, whereas it does not reduce the occurence of CV events and mortality compared to the usual care group in the long term; this finding has induced an early termination of the trial [35••]. The reasons for the lack of difference in CV events may be different: a) a low rate of events that could have reduced the statistical power of the study; b) an improvement in CV risk factors in the usual care group as well; c) a lower use of statins in the intervention group with higher levels of LDL-cholesterol; d) a decrease in body weight may be of paramount importance in the reduction of risk for diabetes, but not so relevant in the reduction of CVD [36, 37].

The results obtained in the PREDIMED study [38••] are completely different; this study was stopped earlier on the basis of clear benefits shown by the two experimental diets. In fact, in this study, two Mediterranean diets supplemented with extra-virgin olive oil or nuts were able to significantly reduce (almost 30 % for both diets) the incidence of major CV events compared to the control diet in high-risk individuals, including subjects with T2D (n = 3,614, almost 50 % of the total population).

Although the early termination of the trial may lead to an overestimation of treatment effects [39], the results suggest that even small changes in diet composition may be really effective, possibly more than weight reduction, in reducing CVD in high-risk individuals such as T2D subjects.

Conclusions

The evidence from studies published in the last 3 years, as a whole, reinforces the principles on which dietary guidelines for diabetes are based.

The only dietary intervention study with hard endpoints (CV events) performed in a population including a relevant number of diabetic patients shows clear and significant benefits of the Mediterranean dietary pattern, independent from body weight change. The other study with hard endpoints, in which the intervention was performed through an intensive lifestyle education program focused on weight reduction, does not show benefits on CV events. This lack of effect may have different explanations as reported before, but, certainly, does not minimize the importance of diet and physical activity in the treatment of T2D, since these changes are able to reduce body weight, the need and the cost of medications, and the rate of sleep apnea, and to improve quality of life and in some cases, achieve diabetes remission.

Other long-term intervention studies with hard endpoints based not only on weight reduction but also on changes in dietary composition are needed in diabetic patients, even if these studies are more and more complicated to carry out due to the lack of funds.

Compliance with Ethics Guidelines

Conflict of Interest

Rosalba Giacco, Claudia Vetrani, Ettore Griffo, and Angela A. Rivellese declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Rosalba Giacco
    • 2
  • Claudia Vetrani
    • 1
  • Ettore Griffo
    • 1
  • Angela A. Rivellese
    • 1
  1. 1.Department of Clinical Medicine and Surgery“Federico II” University of NaplesNaplesItaly
  2. 2.Institute of Food Science, CNR- National Research CouncilAvellinoItaly

Personalised recommendations